EVERSANA

One of the largest independent life sciences commercialization platforms in the US, with a top-tier healthcare advertising agency network (EVERSANA INTOUCH) serving major pharmaceutical and biotech brands

EVERSANA is a Chicago-based life sciences commercialization platform founded in 2018, backed by private equity firms Water Street Healthcare Partners and JLL Partners. The company provides an integrated suite of services designed to help pharmaceutical, biotech, and medical device companies bring products to market and sustain commercial success. Its capabilities span market access and reimbursement, patient support services, specialty distribution, field force deployment, regulatory consulting, and data analytics. A significant dimension of EVERSANA's business is healthcare marketing and advertising, delivered through EVERSANA INTOUCH — a full-service healthcare advertising agency network formed following the December 2021 acquisition of Intouch Group. EVERSANA INTOUCH operates as one of the largest independent healthcare agency networks globally, offering brand strategy, creative development, digital marketing, medical communications, and omnichannel engagement solutions to pharmaceutical and biotech marketers. The agency serves both healthcare professional (HCP) and direct-to-consumer (DTC) audiences across a wide range of therapeutic categories. EVERSANA has grown rapidly through acquisitions and organic expansion, positioning itself as a differentiated alternative to both large CROs and traditional pharma marketing holding companies. Its integrated model — combining commercial operations, patient services, and marketing under one platform — is a core competitive differentiator. In 2025, EVERSANA announced a merger with Waltz Health, further expanding its capabilities in prescription affordability and patient access. The company has no parent company and operates as an independent entity.